Acanfora D, Ciccone MM, Scicchitano P, Acanfora C and Casucci G (2020) Neprilysin inhibitor-angiotensin II receptor blocker combination (sacubitril/valsartan): rationale for adoption in SARS-CoV-2 patients. Eur Heart J Cardiovasc Pharmacother 6:135-136.
Bharatham K, Bharatham N, Park KH and Lee KW (2008) Binding mode analyses and pharmacophore model development for sulfonamide chalcone derivatives, a new class of alpha-glucosidase inhibitors. J Mol Graph Model 26:1202-1212.
Bordoli L, Kiefer F, Arnold K, Benkert P, Battey J and Schwede T (2009) Protein structure homology modeling using SWISS-MODEL workspace. Nat Protoc 4:1-13.
Borson DB, Brokaw JJ, Sekizawa K, McDonald DM and Nadel JA (1989) Neutral endopeptidase and neurogenic inflammation in rats with respiratory infections. J Appl Physiol (1985) 66:2653-2658.
Burrell M, Henderson SJ, Ravnefjord A, Schweikart F, Fowler SB, Witt S, Hansson KM and Webster CI (2016) Neprilysin Inhibits Coagulation through Proteolytic Inactivation of Fibrinogen. PLoS One 11:e0158114.
Dempsey EC, Wick MJ, Karoor V, Barr EJ, Tallman DW, Wehling CA, Walchak SJ, Laudi S, Le M, Oka M, Majka S, Cool CD, Fagan KA, Klemm DJ, Hersh LB, Gerard NP, Gerard C and Miller YE (2009) Neprilysin null mice develop exaggerated pulmonary vascular remodeling in response to chronic hypoxia. Am J Pathol 174:782-796.
El Tabaa MM and El Tabaa MM (2020) New putative insights into neprilysin (NEP)-dependent pharmacotherapeutic role of roflumilast in treating COVID-19. Eur J Pharmacol 889:173615.
Esser N and Zraika S (2019) Neprilysin inhibition: a new therapeutic option for type 2 diabetes? Diabetologia 62:1113-1122.
Goothy SSK and Kumar AHS (2020) Network Proteins of Angiotensin-converting Enzyme 2 but Not Angiotensin-converting Enzyme 2 itself are Host Cell Receptors for SARS-Coronavirus-2 Attachment. BEMS Reports 6:1-5.
Gregoriou GC, Patel SD, Winters BL and Bagley EE (2020) Neprilysin Controls the Synaptic Activity of Neuropeptides in the Intercalated Cells of the Amygdala. Mol Pharmacol 98:454-461.
Hruz T, Laule O, Szabo G, Wessendorp F, Bleuler S, Oertle L, Widmayer P, Gruissem W and Zimmermann P (2008) Genevestigator v3: a reference expression database for the meta-analysis of transcriptomes. Adv Bioinformatics 2008:420747.
Karoor V, Oka M, Walchak SJ, Hersh LB, Miller YE and Dempsey EC (2013) Neprilysin regulates pulmonary artery smooth muscle cell phenotype through a platelet-derived growth factor receptor-dependent mechanism. Hypertension 61:921-930.
Kilroy D and Kumar AHS (2020) Anatomical perspective on the loss of smell and taste sensation in SARS-CoV-2 infection. Anatomy 14:145-149.
Kumar AHS (2020) Molecular Docking of Natural Compounds from Tulsi (Ocimum sanctum) and neem (Azadirachta indica) against SARS-CoV-2 Protein Targets. BEMS Reports 6:11-13.
Liczek M, Panek I, Damianski P, Jeczen O, Jazwiec J, Kuna P and Panek M (2018) Neprilysin inhibitors as a new approach in the treatment of right heart failure in the course of chronic obstructive pulmonary disease. Response to the letter of Siniorakis et al. Adv Respir Med 86:257-259.
Mangiafico S, Costello-Boerrigter LC, Andersen IA, Cataliotti A and Burnett JC, Jr. (2013) Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics. Eur Heart J 34:886-893c.
Mishra A and Dey S (2019) Molecular Docking Studies of a Cyclic Octapeptide-Cyclosaplin from Sandalwood. Biomolecules 9.
Nalivaeva NN, Zhuravin IA and Turner AJ (2020) Neprilysin expression and functions in development, ageing and disease. Mech Ageing Dev 192:111363.
Pavo N, Arfsten H, Cho A, Goliasch G, Bartko PE, Wurm R, Freitag C, Gisslinger H, Kornek G, Strunk G, Raderer M, Zielinski C and Hulsmann M (2019a) The circulating form of neprilysin is not a general biomarker for overall survival in treatment-naive cancer patients. Sci Rep 9:2554.
Pavo N, Gugerell A, Goliasch G, Bartko PE, Arfsten H, Novak JF, Gyongyosi M and Hulsmann M (2019b) Increased granulocyte membrane neprilysin (CD10) expression is associated with better prognosis in heart failure. Eur J Heart Fail 21:537-539.
Renu K, Prasanna PL and Valsala Gopalakrishnan A (2020) Coronaviruses pathogenesis, comorbidities and multi-organ damage - A review. Life Sci 255:117839.
Rice GI, Thomas DA, Grant PJ, Turner AJ and Hooper NM (2004) Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J 383:45-51.
Sagar VK and Kumar AHS (2020) Efficacy of Natural Compounds from Tinospora cordifolia against SARS-CoV-2 Protease, Surface Glycoprotein and RNA Polymerase. BEMS Reports 6:6-8.
Seeliger D and de Groot BL (2010) Ligand docking and binding site analysis with PyMOL and Autodock/Vina. J Comput Aided Mol Des 24:417-422.
Sharma A, Menche J, Huang CC, Ort T, Zhou X, Kitsak M, Sahni N, Thibault D, Voung L, Guo F, Ghiassian SD, Gulbahce N, Baribaud F, Tocker J, Dobrin R, Barnathan E, Liu H, Panettieri RA, Jr., Tantisira KG, Qiu W, Raby BA, Silverman EK, Vidal M, Weiss ST and Barabasi AL (2015) A disease module in the interactome explains disease heterogeneity, drug response and captures novel pathways and genes in asthma. Hum Mol Genet 24:3005-3020.
Shipp MA, Stefano GB, Switzer SN, Griffin JD and Reinherz EL (1991) CD10 (CALLA)/neutral endopeptidase 24.11 modulates inflammatory peptide-induced changes in neutrophil morphology, migration, and adhesion proteins and is itself regulated by neutrophil activation. Blood 78:1834-1841.
Song S, Zhang M, Yi Z, Zhang H, Shen T, Yu X, Zhang C, Zheng X, Yu L, Ma C, Liu Y and Zhu D (2016) The role of PDGF-B/TGF-beta1/neprilysin network in regulating endothelial-to-mesenchymal transition in pulmonary artery remodeling. Cell Signal 28:1489-1501.
Srivastava PK and Fonarow GC (2019) In-Hospital Initiation of Angiotensin Receptor-Neprilysin Inhibitors-The Time Is Now. JAMA Cardiol 4:195-196.
Steiner MK (2009) World Health Organization Class III COPD-associated pulmonary hypertension: are we there yet in understanding the pathobiology of the disease? Chest 136:658-659.
Stower H (2020) Virological assessment of SARS-CoV-2. Nat Med 26:465.
Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson A, Kampf C, Sjostedt E, Asplund A, Olsson I, Edlund K, Lundberg E, Navani S, Szigyarto CA, Odeberg J, Djureinovic D, Takanen JO, Hober S, Alm T, Edqvist PH, Berling H, Tegel H, Mulder J, Rockberg J, Nilsson P, Schwenk JM, Hamsten M, von Feilitzen K, Forsberg M, Persson L, Johansson F, Zwahlen M, von Heijne G, Nielsen J and Ponten F (2015) Proteomics. Tissue-based map of the human proteome. Science 347:1260419.
Wick MJ, Buesing EJ, Wehling CA, Loomis ZL, Cool CD, Zamora MR, Miller YE, Colgan SP, Hersh LB, Voelkel NF and Dempsey EC (2011) Decreased neprilysin and pulmonary vascular remodeling in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 183:330-340.
Yang Z, Lasker K, Schneidman-Duhovny D, Webb B, Huang CC, Pettersen EF, Goddard TD, Meng EC, Sali A and Ferrin TE (2012) UCSF Chimera, MODELLER, and IMP: an integrated modeling system. J Struct Biol 179:269-278.